AnchorDx is a pioneer in early cancer screening and diagnosis products using high-throughput methylation sequencing technology
AnchorDx is a pioneer in early cancer screening and diagnosis products using high-throughput methylation sequencing technology. The company focuses on detecting tumors through blood and urine samples, covering over 70% of high-incidence cancers.